Håkan Björklund joins Avista Capital as healthcare operating executive

Björklund joined Nycomed as CEO following a €377m Nordic Capital-backed MBO in 1999. Nycomed received a €125m investment from Avista in October 2006 and was eventually sold to Takeda Pharmaceuticals for €9.6bn earlier this year.

Previous to his time at Nycomed, Björklund held the position of regional director at Astra (currently known as AstraZeneca) and president of Astra Draco. He has previously served as board member of Coloplast, Lundbeck, and Atos Medical, and as director at Danisco. Björklund holds a PhD in Neuroscience from Karolinska Institutet, Sweden.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• People
• UK / Ireland
• United Kingdom